• Home
  • Corden Pharma International GmbH

Corden Pharma International GmbH

  • Drug Product manufacturing in CordenPharma Lisbon (PT).
About Corden Pharma International GmbH

CordenPharma is a CDMO partner supporting biotech and pharma innovators of complex modalities in the advancement of their drug development lifecycle. Harnessing the collective expertise of the teams across its globally integrated facility network, CordenPharma provides bespoke outsourcing services spanning the complete supply chain, from early clinical-phase development to commercialization. With scientific expertise and partnership at its core, CordenPharma provides customers high-value, end-to-end services with a strategic focus on Peptides, Oligonucleotides, customized Lipid Excipients, Lipid NanoParticles (LNPs), sterile Injectables, and the extensive supply of Small Molecules (both Highly Potent and Regular Potency). The CordenPharma Group is comprised of 11 facilities across Europe and North America. In the 2023 financial year, the organization generated sales of 890 million Euros and had over 3,000 employees. Please visit cordenpharma.com for more information.

Read more Show less
Certifications
  • FDA
    FDA
  • GMP
    GMP
  • ISO
    ISO
  • Other
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • DE
  • 2015
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
View company profile
Contact info
Show contact info Hide contact info
Meet us at

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024
View Exhibitor Profile

Products from Corden Pharma International GmbH (30)

  • CordenPharma Peptides Platform

    Product CordenPharma Peptides Platform

    Your Expert Partner for Peptide APIs
    • >> Proven track record delivering world class manufacturing services from early stage to commercial supply, including complex products (e.g., Linaclotide, Enfuvirtide, Mifamurtide, Eptifibatide, Glatiramer, GLP analogues). • >> Proprietary...
  • CordenPharma Oligonucleotide Platform

    Product CordenPharma Oligonucleotide Platform

    Your Expert Partner for Oligonucleotide APIs

    • Process Development & Small-scale: scale-up to 10 mmol per run(small-scale equipment can also support early-stage supply)

    • Scale-up & Small to Medium-scale: scale-up to 100 mmol per run(supported by OligoPilotTM equipment)

    • ...
  • CordenPharma Lipids & Carbohydrate Platform

    Product CordenPharma Lipids & Carbohydrate Platform

    Your Expert Partner for Standard & Proprietary Lipids & Carbohydrates
    • >> A specialized Lipids offering including custom and standard lipids (Glycero-Phospholipids, Sphingolipids, Phosphocholine, Pegylated, and Cationic Lipids). • >> Lipids for support of mRNA vaccine ...
  • CordenPharma Injectables Platform

    Product CordenPharma Injectables Platform

    Your Expert Partner for Clinical & Commercial Injectable Drug Product Supply
    • >> Wide & balanced range of injectable services incl. capability for combining injectable drugs and devices (combination products) • >> Aseptic and Terminal Sterilization Fill & Finish Technologies f...
  • CordenPharma Highly Potent & Oncology Platform

    Product CordenPharma Highly Potent & Oncology Platform

    One Source for Highly Potent & Oncological Products
    • Integrated Supply: APIs & Oral / Sterile Drug Products • State-of-the-art facilities able to handle API and Drug Product of the highest potency • Development, clinical trial and commercial manufacturing • Full-service offering includi...
  • CordenPharma Small Molecules Platform

    Product CordenPharma Small Molecules Platform

    Full-Service Partner of Choice from Advanced Intermediates to Drug Products • Integrated network of cGMP facilities across Europe and US • 1,200 m3 of volumetric capacity in 20 L - 28,000 L reactors with various materials of construction • Clinical (Phase I-III) and ongoing commercial supply to multiple ...
  • CordenPharma Peptides APIs

    Product CordenPharma Peptides APIs


    CordenPharma is one of the leading manufacturers of peptide Active Pharmaceutical Ingredients (APIs) with an unprecedented track record of experience in supporting our customer along the value chain ranging from early clinical to commercial in worldwide markets. Today we support more than 50 cGMP devel...
  • CordenPharma Fully-Integrated Supply

    Product CordenPharma Fully-Integrated Supply

    CordenPharma’s vertically-integrated supply chain model provides development & manufacturing expertise spanning the complete GMP supply chain. Beginning with regulated Key Raw Materials and Non-GMP Intermediates, our sister organization WeylChem supports back integration to sec...
  • CordenPharma Sterile Liquid Drug Products

    Product CordenPharma Sterile Liquid Drug Products

    Sterile Drug Product manufacturing requires dedicated and specialized capabilities which are in compliance with FDA aseptic guidance and EMA regulatory requirements. CordenPharma has a long track record of experience in manufacturing Parenteral Sterile Solutions and Emulsions in different pharmaceutical fo...
  • CordenPharma Oral Formulation Tablets & Capsule Drug Products

    Product CordenPharma Oral Formulation Tablets & Capsule Drug Products

    CordenPharma’s service offerings include a wide range of products, formulations and services supporting new chemical entities, re-formulations and generics:
    • Powder & Granule-filled Capsules • Powder Granules & Pellets • Immediate Release Tablets • Controlled Release Tablets • Mini-tablets...
  • CordenPharma Lipids & Carbohydrates APIs

    Product CordenPharma Lipids & Carbohydrates APIs

    LipidsCordenPharma’s scientists have mastered the chemical total synthesis of complex derivatized phospholipids from multi-gram to multi-kilogram scale and are renowned for their contract lipid and phospholipid manufacturing expertise. Our large-scale proprietary cGMP manufacturing processes star...
  • CordenPharma Derivatized Phospholipids - DPPC & More

    Product CordenPharma Derivatized Phospholipids - DPPC & More

    CordenPharma’s expert lipid manufacturers have mastered the chemical total synthesis of complex phospholipid derivatives from multi-gram to multi-kilogram scale and are renowned for their contract lipid and phospholipid molecule manufacturing expertise. Our large-scale proprietary cGMP manufacturing proces...
show all 30 products

Corden Pharma International GmbH Resources (17)

  • CordenPharma signs billion dollar agreement to manufacture new peptide

    News CordenPharma signs billion dollar agreement to manufacture new peptide

    CordenPharma, the CDMO specialising in APIs, lipid excipients, and drug products, signs a new billion dollar contract to expand its manufacturing capabilities. 
    10 Jan 2023
  • Webinar On Demand > Critical Aspects of a Robust Highly Potent Compound Program > The Importance of Understanding Intangible Elements of Containment

    Video Webinar On Demand > Critical Aspects of a Robust Highly Potent Compound Program > The Importance of Understanding Intangible Elements of Containment

    Register for this Live (4-4-18) or on Demand webinar to learn how the most important (and often over-looked) aspect to a robust containment program is the strength of the intangible, softer elements. Discuss how to maximize the success of your engineering control investments and allow for continued alignment to your company’s commitment to providing a workplace free of recognized health & safety hazards.
    2021-06-21
  • CordenPharma joins sustainability initiative to achieve Net Zero

    News CordenPharma joins sustainability initiative to achieve Net Zero

    The CDMO has joined the environmental initiative looking to align private sector companies with those aims upheld by the Paris Agreement to reduce global warming. 
    5 Dec 2022
  • Webinar On Demand > From Market Compliance to Business Supply: The Necessity for Serialization

    Video Webinar On Demand > From Market Compliance to Business Supply: The Necessity for Serialization

    This recorded webinar archive addresses the necessity of serialization from market compliance to business supply. Expert speaker Mario Scigliano covers all aspects of serialization, from line choice and regulation approach to management of data and related products.

    2021-06-21
  • CPHI Frankfurt 2022: Innovator Interview – CordenPharma

    News CPHI Frankfurt 2022: Innovator Interview – CordenPharma

    In this interview from CPHI Frankfurt 2022, we speak to Dr Michael Quirmbach of CordenPharma about his role as President and CEO and what CordenPharma is bringing to the pharma industry.
    15 Nov 2022
  • Generic API List

    Brochure Generic API List

    For generic drug companies, CordenPharma supplies more than 50 Active Pharmaceutical Ingredients (APIs), including controlled substances, for pain management, cardiovascular, gastrointestinal, central nervous system, anti-infective and respiratory indications. We manufacture these products using complex and technical expertise while maintaining a long-standing reputation of quality and reliability.

  • Press Release > CordenPharma Colorado Expands Lipid Excipients Purification

    News Press Release > CordenPharma Colorado Expands Lipid Excipients Purification

    Luxembourg, 19 April 2021 -- In response to the COVID-19 pandemic, mRNA (messenger RNA) vaccines have catapulted to center stage of the pharmaceutical and biotechnology industry. As of early 2021, there are eight ongoing human trials for mRNA vaccines led by Moderna, BioNTech / Pfizer, CureVac, Sanofi / TranslateBio, Arcturus / Duke-NUS Medical School (Singapore), Imperial College London, Chulalongkorn University (Thailand), and Providence Therapeutics.
    21 Jun 2021
  • Catalog Lipid List > Readily Available Phospholipids

    Brochure Catalog Lipid List > Readily Available Phospholipids

    CordenPharma offers a wide selection of Readily Available Derivatized Phospholipids suitable for Research & Discovery for purchase in convenient 1 g and 10 g pack sizes.
  • Top 5 Industry Content Reads on CPHI Online This Month

    News Top 5 Industry Content Reads on CPHI Online This Month

    If you’re looking for news, product information and market trends from leading pharma companies, the CPHI-Online.com Company Showcases are a great resource for buyers who want to stay up to date, browse product portfolios and find the right partner.

    18 Jan 2021
  • LIVE WEBINAR > Your Injectable Roadmap: Tues Oct 13, 16:00 CEST / 10 EDT

    Webinar LIVE WEBINAR > Your Injectable Roadmap: Tues Oct 13, 16:00 CEST / 10 EDT

    Speakers: Mark Chipperfield (Corvus Ltd), Fabio Stevanon (CordenPharma), Umberto Romeo (CordenPharma)
    Key Learning Objectives:
    Review the fundamentals of combined injectable delivery device - drug products. Get an update on the latest regulation landscape for combined drug-device products, including some technical challenges for injectable Pre-Filled Syringes (PFS) & Auto-injectors. Gain insight into sound Injectable Drug Product strategy from a Full-Service CDMO industry leader. Learn about recent injectable industry changes facing Pharma, especially in the “New Normal” COVID-19 era, and how CordenPharma’s successful response & expanded capabilities can best support your drug development goals. Learn from an R&D Expert on ways to efficiently develop & commercialize an injectable drug.
    2022-05-06
  • Press Release > Pandemic Preparedness: WACKER & CordenPharma Will Produce mRNA Vaccines for Germany When Needed

    News Press Release > Pandemic Preparedness: WACKER & CordenPharma Will Produce mRNA Vaccines for Germany When Needed

    11 April 2022 - Munich / Halle / Plankstadt
    • WACKER AND CORDENPHARMA TO BECOME PART OF GERMANY’S PANDEMIC PREPAREDNESS PLANTHE TWO COMPANIES WILL BE READY TO PRODUCE MRNA VACCINES FOR THE GERMAN GOVERNMENT IF THE COVID-19 PANDEMIC CONTINUES OR A NEW PANDEMIC OCCURS
    • WACKER AND CORDENPHARMA JOINTLY COVER THE ENTIRE MANUFACTURING CHAIN FOR VACCINES
    • HALLE WILL BECOME A COMPETENCE CENTER FOR PRODUCING MRNA VACCINES, WITH ADDITIONAL CAPACITY FOR OTHER CUSTOMERS AS WELL
    • CORDENPHARMA WILL USE ITS YEARS OF EXPERIENCE IN PRODUCING CUSTOM AND STANDARD LIPIDS AND IN FILL & FINISH
    • WACKER INTENDS TO INVEST OVER €80 MILLION ANNUALLY IN EXPANDING THE GROWTH OF ITS BIOTECHNOLOGY BUSINESS OVER THE NEXT FEW YEARS
    27 Aug 2020
  • Join CordenPharma’s Live Injectable Webinar: Tuesday, October 13th at 16:00 CEST / 10 EDT

    Video Join CordenPharma’s Live Injectable Webinar: Tuesday, October 13th at 16:00 CEST / 10 EDT

    Your Injectable Roadmap for Combined Drug Product - Delivery Device Regulations & Evolving Capabilities in the New Normal > How a Full-Service CDMO Supports Pharma
    2021-06-21
  • Press Release > CordenPharma & Moderna Extend Lipid Supply Agreement for Moderna’s (mRNA-1273) Vaccine Candidate

    News Press Release > CordenPharma & Moderna Extend Lipid Supply Agreement for Moderna’s (mRNA-1273) Vaccine Candidate

    Luxembourg, 28 May 2020 -- CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug Products & Pharmaceutical Packaging, announces the signing of an amendment to their existing manufacturing agreement with Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients.
    23 Jun 2020
  • Brochure > Weylchem InnoTec

    Brochure Brochure > Weylchem InnoTec

    WeylChem InnoTec are your innovative partner to the fine chemical, pharmaceutical and electronic industry. We provide world-class analytical, modern developmental and tailor-made manufacturing services. With our competencies in Analytics, Contract Development & Custom Synthesis, WeylChem InnoTec is your agile development partner.

    Our Services:AnalyticsContract DevelopmentCustom SynthesisAdvanced technologies
    How We Support You in Different Markets:
    Organic ElectronicsCatalysts and LigandsSustainable ChemistryPharmaceutical IntermediatesAgrochemicalsVisit weylchem-innotec.com or email [email protected] for more information.
  • CordenPharma ONE PARTNER Video

    Video CordenPharma ONE PARTNER Video

    As your ONE PARTNER, CordenPharma provides you with an integrated solution spanning all product life cycle stages, from preclinical to commercial, supported by dedicated regulatory and project management services.
    2021-06-21
  • Peptides Technology Platform

    Brochure Peptides Technology Platform

  • API Crystallization Services

    Brochure API Crystallization Services